pSMART-sgRNA (Sp) Citations (10)

Originally described in: A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells.
Howden SE, McColl B, Glaser A, Vadolas J, Petrou S, Little MH, Elefanty AG, Stanley EG Stem Cell Reports. 2016 Sep 13;7(3):508-17. doi: 10.1016/j.stemcr.2016.07.001. Epub 2016 Aug 4. PubMed Journal

---

Articles Citing pSMART-sgRNA (Sp)

Articles
Simultaneous reprogramming and gene editing of human fibroblasts. Howden SE, Thomson JA, Little MH. Nat Protoc. 2018 May;13(5):875-898. doi: 10.1038/nprot.2018.007. Epub 2018 Apr 5. PubMed
Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing. Hosseini Far H, Patria YN, Motazedian A, Elefanty AG, Stanley EG, Lamande SR, Bateman JF. Stem Cell Res. 2019 May;37:101449. doi: 10.1016/j.scr.2019.101449. Epub 2019 Apr 23. PubMed
The use of simultaneous reprogramming and gene correction to generate an osteogenesis imperfecta patient COL1A1 c. 3936 G>T iPSC line and an isogenic control iPSC line. Howden S, Hosseini Far H, Motazedian A, Elefanty AG, Stanley EG, Lamande SR, Bateman JF. Stem Cell Res. 2019 Jul;38:101453. doi: 10.1016/j.scr.2019.101453. Epub 2019 May 4. PubMed
CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line, MCRIi019-A. Kung LHW, Sampurno L, Yammine KM, Graham A, McDonald P, Bateman JF, Shoulders MD, Lamande SR. Stem Cell Res. 2020 Oct;48:101962. doi: 10.1016/j.scr.2020.101962. Epub 2020 Sep 6. PubMed
Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing. Lilianty J, Bateman JF, Lamande SR. Stem Cell Res. 2021 Oct;56:102515. doi: 10.1016/j.scr.2021.102515. Epub 2021 Aug 25. PubMed
Using CRISPR/Cas9 to generate a heterozygous COL2A1 p.R719C iPSC line (MCRIi019-A-6) model of human precocious osteoarthritis. Yammine KM, Mirda Abularach S, Sampurno L, Bateman JF, Lamande SR, Shoulders MD. Stem Cell Res. 2023 Mar;67:103020. doi: 10.1016/j.scr.2023.103020. Epub 2023 Jan 6. PubMed
Generation of heterozygous (MCRIi030-A-1) and homozygous (MCRIi030-A-2) NR2F2/COUP-TFII knockout human iPSC lines. Ferreira LGA, Cabral-da-Silva MC, Pachernegg S, van den Bergen JA, Robevska G, Vlahos K, Howden SE, Ng ES, Dias-da-Silva MR, Sinclair AH, Ayers KL. Stem Cell Res. 2024 Apr;76:103374. doi: 10.1016/j.scr.2024.103374. Epub 2024 Mar 2. PubMed
Generation of a homozygous (MCRIi031-A-3) WT1 knockout human iPSC line. Pachernegg S, Robevska G, Ferreira LGA, van den Bergen JA, Vlahos K, Howden SE, Sinclair AH, Ayers KL. Stem Cell Res. 2024 Sep;79:103494. doi: 10.1016/j.scr.2024.103494. Epub 2024 Jul 10. PubMed
ErbB4 precludes the occurrence of PTSD-like fear responses by supporting the bimodal activity of the central amygdala. Sung K, Jeong MJ, Yoo T, Jung JH, Kang S, Yoo JY, Kim HJ, Park K, Pyo JH, Lee HY, Koo N, Choi SH, Kim JH. Exp Mol Med. 2024 Dec;56(12):2703-2713. doi: 10.1038/s12276-024-01365-1. Epub 2024 Dec 2. PubMed
GluN2B-mediated regulation of silent synapses for receptor specification and addiction memory. Kim HJ, Lee S, Kim GH, Sung K, Yoo T, Pyo JH, Jo HJ, Lee S, Lee HY, Jung JH, Lee KJ, Kim JH. Exp Mol Med. 2025 Feb;57(2):436-449. doi: 10.1038/s12276-025-01399-z. Epub 2025 Feb 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.